USD10
XENE Shares
About Xenon PharmaceuticalsXenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.
USD10
XENE Shares
About Xenon PharmaceuticalsXenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.
Stats
TRADING WINDOW
Closed
OPENS AT
Not enough data
MARKET CAP
$6.6B
OPEN PRICE
$66.20
LOW (1Y)
$30.00
HIGH (1Y)
$72.66
LOW (24H)
$66.18
HIGH (24H)
$69.58
VOLUME (24H)
$1.34M
10.62%
Price history
Time | Price | Change |
|---|---|---|
Today | $66.20 | |
1 Day | $66.16 | |
1 Week | $69.16 | |
1 Month | $53.36 | |
1 Year | $31.49 |
Past performance is not a reliable indicator of future results.
Discover more
Popular cryptocurrencies
Popular price predictions
Legal
Information is provided for informational purposes only, and is not investment advice. This is not an invitation, inducement or recommendation to buy any particular asset, or to employ any particular investment strategy. Coinbase makes no representation as to the accuracy, suitability or validity of any information provided.All ticker names are trademarks of their respective holders. Any ticker reference does not imply affiliate with or endorsement by a third-party. Real-time prices are sourced from third parties, but not from all markets. Source: Nasdaq Last Sale. Morningstar data ©2026.